FDOPA-(18F): a PET radiopharmaceutical recently registered for diagnostic use in countries of the European Union

Autor: Yanna-Marina Chevalme, Françoise Montravers, Jean-Philippe Vuillez, Michel Zanca, Charles Fallais, Jean Oustrin, Jean-Noël Talbot

Publikováno v: Brazilian Archives of Biology and Technology, Vol 50, Iss spe, Pp 77-90 (2007)

Positron emission tomography (PET) and its recent update PET/CT are very effective diagnostic tools for non-invasive imaging of metabolic or functional disorders in target tissues. The clinical usefulness of fluorodeoxyglucose-(18F) (FDG) has been no

Externí odkaz: https://doaj.org/article/2ecef26b637b4465947f88f246f18502

Current evaluation of the clinical utility of Fluoromethylcholine-(18F) PET/CT in Prostate Cancer

Autor: Yanna-Marina Chevalme, Jean-Noël Talbot

Publikováno v: Brazilian Archives of Biology and Technology, Vol 51, Iss spe, Pp 71-75 (2008)
Brazilian Archives of Biology and Technology v.51 n.spe 2008
Brazilian Archives of Biology and Technology
Instituto de Tecnologia do Paraná (Tecpar)
instacron:TECPAR
Brazilian Archives of Biology and Technology, Volume: 51, Issue: spe, Pages: 71-75, Published: DEC 2008

This short review is dedicated to the current status of the assessment of a new PET radiopharmaceutical, fluoromethylcholine-(18F) or FCH, which is taken-up by prostate cancer tissue, in contrary to fluorodeoxyglucose-(18F) or FDG. It seems that FCH

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdba6e6d8dc328a4b2c5e962653dcf10
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132008000700012